컨텐츠 내용을 수정할 수 있습니다
The core of psychiatric nursing isn't just matching a diagnosis. It's about first looking for sudden changes and medical causes, then evaluating current symptoms, function, and safety, and finally choosing the next action based on treatment response and the acuity of medication side effects. The same anxiety, agitation, or auditory hallucinations will have different priorities depending on whether they stem from delirium, withdrawal, drug toxicity, a mood disorder, or psychosis.
Core Goal: Make your clinical judgment in this order: ABCs, vital signs, level of consciousness, hypoglycemia, hypoxia, intoxication/withdrawal → acute delirium screening → safety regarding suicide, homicide, nutrition, and dehydration → symptom clusters and function → medication, interactions, and adherence history → acuity of side effects → prescriptions and team-based interventions → reassessment of response.
In local feedback materials, we've only seen recurring themes like depression, bipolar disorder, schizophrenia, PTSD, eating disorders, somatic symptoms, personality disorders, substance use, sleep, adverse psychotropic drug reactions, and ECT. We haven't reconstructed actual test questions, answer choices, tables, or images. After removing stigmatizing language, fixed time limits, and rigid protocols, this content was independently rewritten using current, publicly available resources from NIMH, VA/DoD, FDA, DailyMed, and MedlinePlus.
Check the airway, breathing, circulation, oxygenation, vital signs, level of consciousness, blood glucose, temperature, trauma, seizures, overdose, and severe dehydration. Even if a patient is having hallucinations or is agitated, don't delay stabilizing the ABCs and calling for emergency help.
An onset within hours to days, fluctuations throughout the day, poor concentration, and a change in the level of consciousness should make you suspect delirium first. Look for causes like infection, hypoxia, metabolic imbalances, pain, surgery, medications, or withdrawal.
Check for recent starts, dose increases, or discontinuations of prescription drugs, over-the-counter meds, and supplements, as well as alcohol and substance use, the time of last use, and any history of withdrawal or seizures. Don't just rely on the patient's self-report; cross-reference with prescription lists, family, the pharmacy, and lab results.
Assess for suicidal or homicidal ideation, command hallucinations, self-care, sleep, food and fluid intake, impulse control, judgment, gait and fall risk, and support systems and housing. A diagnosis cannot replace this assessment.
Compare the patient's current state to their usual cognitive, functional, and mental status and reassess repeatedly. A single 'normal' test result or a moment of quiet calm does not rule out an acute risk or a medical cause.
| Clue | Priority Interpretation | Next Action |
|---|---|---|
| Sudden confusion & fluctuating attention | Possible delirium or acute change in brain function | Evaluate for causes: vital signs, oxygen, blood glucose, infection, electrolytes, medications, withdrawal |
| New visual hallucinations & altered consciousness | Do not assume this is a primary psychotic disorder | First, check for neurological, toxic, and medical causes and ensure safety |
| Decreased need for sleep & increased energy over several days | Possible mania/hypomania, or substance/medication-induced | Assess for functional impairment, risky behavior, psychosis, substance/medication use, and past episodes |
| Fever, rigidity, confusion | Possible life-threatening medication-related syndrome | Hold the suspected drug, initiate emergency evaluation, and monitor vital signs and organ function |
Centered on a depressed mood or a loss of interest/pleasure, you'll check for changes in sleep, appetite/weight, energy, psychomotor activity, concentration/decision-making, feelings of guilt/worthlessness, and thoughts of death or suicide. You must also evaluate the persistence of symptoms, functional impairment, and the influence of medical conditions, medications, and substances.
Ask directly about suicidal thoughts and assess their current nature: the plan, intent, access to means, past behavior, and protective factors. A single statement like "I don't have suicidal thoughts" does not confirm safety.
Check for any past history of an abnormally elevated or irritable mood, increased energy/activity, a decreased need for sleep, racing thoughts/speech, or risky behavior. This is especially crucial before starting antidepressant monotherapy.
Review for thyroid issues, anemia, pain, infection, neurological conditions, medications like steroids, alcohol and substance use, the pregnancy/postpartum context, and sleep disorders.
For severe lethargy, instead of saying "cheer up," offer a choice of single-step activities like washing up, drinking water, having a short meal, or taking a brief walk, and provide factual feedback on their achievement.
| Observation | Interpretation to watch for | Nursing focus |
|---|---|---|
| Sleep and appetite improve first | Does not mean mood recovery is complete | Reassess increased energy and any change in suicide capability |
| Agitation, insomnia, or increased impulsivity | Early side effects, mixed features, or possible switch to mania | Report to prescriber immediately; check safety and medication history |
| Accompanied by delusions or auditory hallucinations | Psychotic features of severe depression or another cause | Reality testing, command content and safety, medical/substance differentiation |
| Sadness after a loss | Do not rigidly split normal grief from depressive disorder | Assess duration, function, self-blame, hopelessness, safety, and cultural context |
Mania isn't just about feeling good. It involves an abnormally elevated, expansive, or irritable mood along with increased energy and goal-directed activity, decreased need for sleep, grandiosity, pressured speech, flight of ideas, distractibility, and risky behaviors — and it can seriously impair functioning. When depressive and manic symptoms appear together in a mixed episode, safety assessment becomes especially critical.
| Domain | Changes seen in mania | Nursing judgment |
|---|---|---|
| Safety & judgment | Impulsivity, overspending, sexual/driving/business risks, aggressive reactions | Specify current risks and actual access; set consistent limits |
| Sleep | Decreased need for sleep rather than insomnia with fatigue from lack of sleep | Low-stimulation environment, activity regulation, monitor sleep trends and medication response |
| Nutrition & hydration | Constantly moving, missing meals and fluids | Offer easy-to-eat meals and fluids rather than insisting on long sit-down meals |
| Communication | Rapid speech, abruptly shifting topics, easily distracted | Short, concrete single sentences; one request at a time; avoid arguments |
| Medication | Possible temporal link to antidepressants, steroids, stimulants, etc. | Review all prescriptions, OTCs, and substances; report immediately instead of discontinuing on own |
| Symptom Domain | Examples | Nursing Focus |
|---|---|---|
| Positive | Delusions, hallucinations, disorganized thinking/behavior | Check distress, functioning, command content, safety, and coping — not whether the content is factually true |
| Negative | Reduced emotional expression, low motivation, reduced speech, social withdrawal | Don't label the person as lazy or uncooperative; support them with small goals and functional assistance |
| Cognitive | Difficulties with attention, working memory, planning, and problem-solving | Use brief information, repetition, visual cues, verify understanding, and support daily living |
| Mood & Suicide | Depression, hopelessness, anxiety, possible suicidal thoughts | Conduct a direct safety assessment, separate from the diagnosis |
| Medication & Physical | Movement-related side effects, metabolic abnormalities, smoking, cardiovascular risk | Track changes in psychotic symptoms and medication adverse reactions separately |
In a first episode of psychosis, we evaluate for medical causes such as substance or medication use, delirium, seizure or neurological conditions, and endocrine or infectious disorders. The diagnosis itself does not mean violence; risk assessment is based on specific factors like current threats, plans, means, access, control, past behavior, and intoxication.
Function-focused questions: Don’t stop at “What diagnosis did you receive?” Ask, “How have the voices changed your sleep, eating, taking medication, or going out?” and “Are there moments when it’s hard to keep yourself safe?”
Acknowledge the distress of the experience, such as “I don’t hear that sound, but I can see it’s very real to you,” and ask about content, commands, control, and coping. Don’t play along with the hallucination or agree it’s real.
Rather than persuading about right or wrong, check emotions and current safety, and connect to reality-based activities. Detailed interrogation can increase anxiety.
Directly assess who is told to do what, intent, means, access, past compliance, ability to refuse, and current control, and activate a safety pathway appropriate to the acuity level.
Don’t see unresponsiveness or reduced movement as stubbornness or choice. Evaluate urgently, including risks of dehydration, malnutrition, blood clots, and pressure injuries, as well as medication, neurological, and metabolic causes.
State what you actually see, like “You seem to be listening to something.”
Ask directly what the person is experiencing, how distressing it is, and how much control they feel they have.
Check for command hallucinations, self-harm, harm to others, access to means, and any medical abnormalities.
Pick from possible strategies such as telling a staff member, using a quiet space, or engaging in reality-based activities.
Check whether distress, behavior, functioning, or medication response has actually changed.
PTSD is assessed by looking for persistent re-experiencing, avoidance, negative changes in cognition and mood, and changes in arousal and reactivity that interfere with functioning. Also check whether symptoms are better explained by medications, substances, or another medical condition. Reactions after trauma vary, and not everyone goes on to develop PTSD.
| Symptom cluster | Examples | Nursing approach |
|---|---|---|
| Re-experiencing | Intrusive memories, nightmares, flashbacks, physical tension | Orient to current time and place, sensory grounding, breathing and a safe space |
| Avoidance | Avoiding trauma-related thoughts, feelings, or places | Explain treatment options without pushing for detailed rehashing before the person is ready |
| Cognition & mood | Guilt, numbness, negative beliefs, feeling disconnected | Check functioning, depression, and suicide risk while offering nonjudgmental support |
| Arousal & reactivity | Hypervigilance, exaggerated startle, sleep/concentration problems, irritability | Give predictable explanations, avoid sudden touch, and adjust environmental stimulation |
Rule out medical causes first — chest pain, shortness of breath, risk of syncope — then reduce stimulation and support the person with short, calm sentences and slow breathing. Hold off on complex education during acute panic.
Don’t ridicule compulsions or suddenly forbid all of them. Assess functioning, skin breakdown, nutrition, and time consumed, and support gradual exposure and response prevention according to the treatment plan.
Look at how the feared object or situation and the avoidance affect functioning. Don’t force a confrontation or permanently accommodate the avoidance — support a prepared, step-by-step treatment approach.
Check for pain, breathing disorders, substances, medications, mania, and environmental factors first. Prioritize CBT-I–based stimulus control and a consistent wake-up time. Don’t apply a rigid rule like “everyone must get out of bed after exactly 30 minutes” to every person.
Distinguishing sleep issues: Insomnia — feeling tired but unable to fall asleep — is different from the reduced need for sleep seen in mania, where the person sleeps very little yet doesn’t feel fatigued. Snoring, apnea, and daytime sleepiness should prompt an evaluation for sleep apnea.
Eating disorders are not a choice or a lack of willpower, and they can occur in people of any age, gender, race, or weight. Even when someone’s weight looks “normal,” serious electrolyte imbalances, arrhythmias, dehydration, and malnutrition can still be present.
| Assessment area | Risk clues | Nursing actions |
|---|---|---|
| Circulation & cardiac | Syncope, bradycardia or tachycardia, hypotension, orthostatic changes, chest pain | Monitor vitals and ECG, ensure fall safety, and obtain immediate medical evaluation |
| Electrolytes & fluid | Vomiting, laxative or diuretic use, dehydration, muscle weakness, arrhythmias | Monitor electrolytes, renal function, and intake/output trends as prescribed |
| Refeeding | Starting nutrition after prolonged restriction or severe nutritional deficiency | Follow the specialized team’s plan; monitor phosphorus, potassium, magnesium, fluid status, and cardiac/neurologic changes |
| Meal support | Meal avoidance, binge–purge behaviors, severe anxiety | Use a predictable meal and observation plan, neutral nonjudgmental language, and check safety after behaviors |
| Psychiatric safety | Depression, anxiety, obsessions/compulsions, suicidal thoughts, self-harm | Conduct direct safety assessment and link to treatment while simultaneously stabilizing the person physically |
| Category | Core feature | Nursing approach |
|---|---|---|
| Somatic symptom disorder | Excessive thoughts, anxiety, and behaviors related to actual physical symptoms; there may be a medical cause for the symptoms | Evaluate new warning signs while managing with a consistent team, scheduled appointments, and functional goals |
| Illness anxiety disorder | Persistent anxiety about having a serious illness even when symptoms are absent or mild | Address health anxiety and functioning with planned evaluations rather than simply offering repeated reassurance |
| Functional neurological symptom disorder | Changes in neurological function, diagnosed by clinical inconsistency clues | Respect the symptoms as real and support safety, rehabilitation, and functional recovery |
| Factitious disorder | Intentional symptom fabrication driven by an internal motivation to assume the sick role, when proven | Avoid solo confrontation; use objective documentation, a team approach, and safety assessment |
| Malingering | Intentional falsification for external gain, when proven; this is not a psychiatric diagnosis | Don’t stigmatize based on suspicion alone; evaluate using objective inconsistencies and institutional procedures |
Therapeutic statement: “It sounds like these symptoms are really having a big impact on your daily life. Let’s first check for any new warning signs today, and then our team will regularly track your symptoms and functioning together.”
A personality disorder isn’t diagnosed based on a single behavior or a difficult relationship. A professional assessment confirms that long-standing patterns of inner experience and behavior, appearing across many situations, are affecting functioning and relationships. Don’t pin the cause on one specific parenting experience.
You may see difficulty regulating emotions, impulsivity, and an unstable sense of self and relationships. Don’t dismiss self-harm or suicidal statements as “attention-seeking” — assess the current risk every single time.
Different team members shouldn’t make different promises. Calmly explain which behaviors are acceptable and which are not, along with the reasons. Validate the emotions while keeping clear limits around dangerous behaviors.
Dialectical behavior therapy teaches mindfulness, distress tolerance, emotion regulation, and interpersonal effectiveness skills. During a crisis, connect the person back to their existing coping plan and the skills they can actually use right now.
Don’t use the diagnosis to predict risk. Objectively assess current behavior, specific threats, rule violations, impulsivity, substance use, and access. Avoid getting drawn into emotional arguments.
| Feature | Delirium | Major neurocognitive disorder |
|---|---|---|
| Onset | Acute change over hours to days | Gradual change, usually over months to years |
| Course | Can fluctuate significantly throughout the day | Relatively stable but can progress |
| Attention & consciousness | Decreased attention and altered level of consciousness are key | May be relatively preserved in early stages |
| Cause | Acute causes such as infection, hypoxia, metabolic issues, medications, surgery, pain, or withdrawal | Various chronic causes like neurodegeneration or vascular issues |
| Priority actions | Treat the cause and support safety, hydration, oxygenation, sensory input, and sleep | Support functioning, safety, decision-making, and caregivers with a long-term plan |
A person with dementia can also develop a new delirium. Don’t just chalk it up to “their dementia” — look for a sharp change from their baseline in attention, alertness, or behavior. Support them with glasses and hearing aids, day-night cues, pain and bowel/bladder management, hydration and nutrition, mobility, and sleep. Avoid unnecessary restraints and sedating medications.
| Condition | Key clues | Priority nursing care |
|---|---|---|
| Opioid overdose | Hard to wake, slow or shallow breathing, possible cyanosis and bradycardia | Call emergency, support airway and ventilation, give naloxone, monitor for repeated response and re-sedation |
| Opioid withdrawal | Dilated pupils, runny nose and tearing, pain, vomiting and diarrhea, restlessness | Assess dehydration, electrolytes, pregnancy, and comorbidities; relieve symptoms and link to ongoing treatment |
| Alcohol withdrawal | Tremors, anxiety, sweating, tachycardia, insomnia, progressing to possible seizures and delirium | Use standardized tools and prescribed medications; monitor vital signs, neurological status, electrolytes, and fall risk |
| Sedative-hypnotic withdrawal | Anxiety, insomnia, tremors, possible seizures and delirium | Avoid abrupt self-discontinuation; provide medically supervised tapering and monitoring |
| Stimulant intoxication | Agitation, hypertension and tachycardia, chest pain, hyperthermia, paranoia | Provide a low-stimulation environment; assess cardiovascular status, temperature, hydration, and safety; deliver emergency treatment |
| Class | Key observations | Important teaching |
|---|---|---|
| SSRI·SNRI | GI effects, sleep disturbance/agitation, sexual dysfunction, bleeding risk, possible hyponatremia | Effects take time; avoid abrupt self-discontinuation; report early changes in suicidality or mania |
| TCA | Anticholinergic effects, orthostatic hypotension, sedation, cardiac conduction/overdose toxicity | Assess for falls, constipation, urinary retention, and overdose safety |
| MAOI | Hypertensive crisis and serious drug/food interactions | Follow prescribed restrictions and washout periods exactly; check before starting any new medication or supplement |
| bupropion | Insomnia/activation, seizure risk | Verify contraindications such as eating disorder or seizure history and appropriateness of the prescription |
| mirtazapine | Sedation, appetite/weight changes | Evaluate effects together with individual symptoms, fall risk, and metabolic context |
Monitor for changes in anxiety, agitation, insomnia, impulsivity, suicidal thoughts, and unusual energy or decreased need for sleep.
Check the full list of other antidepressants, tramadol, linezolid, triptans, dextromethorphan, St. John's wort, and more.
Dizziness, paresthesia, anxiety, and flu-like symptoms can be mistaken for relapse. Instead of stopping abruptly on your own, work with the prescriber on a tapering plan.
If decreased need for sleep, increased talking/energy/activity, or impulsivity emerge, don't view it as simple improvement — report it immediately.
| Drug | Core monitoring | Clues to report immediately |
|---|---|---|
| lithium | Prescribed blood levels, renal/thyroid/electrolytes, hydration/sodium, pregnancy, interactions | New vomiting/diarrhea, coarse tremor, ataxia, slurred speech, confusion |
| valproate·divalproex | Liver function, CBC/platelets, pregnancy potential, bleeding/sedation/weight | Severe abdominal pain/vomiting, jaundice, abnormal bleeding, altered consciousness |
| carbamazepine | CBC, liver/sodium, skin, interactions and genetic risk assessment | Fever/sore throat, severe rash/mucosal lesions, confusion/seizure |
| lamotrigine | Slow titration, skin/mucosa and systemic hypersensitivity, interactions | New rash, blistering/mucosal pain, fever/lymph node/organ symptoms |
| Domain | Observations | Nursing actions |
|---|---|---|
| Movement | Acute dystonia, akathisia, parkinsonism, tardive dyskinesia | Document onset, pattern, and functional impact; report to prescriber — treatments differ |
| Metabolic | Weight/waist circumference, blood pressure, blood glucose, lipids | Check baseline and trends; provide non-stigmatizing lifestyle and medical support |
| Cardiovascular | Orthostatic hypotension, syncope, QT risk | Check falls, vitals, cardiac history/electrolytes/interactions, and prescribed ECG |
| Endocrine/sexual | Prolactin-related changes, sexual/menstrual changes | Ask about sensitive symptoms privately; counsel before stopping medication |
| clozapine | ANC, infection, chest pain/dyspnea, seizures, severe constipation, metabolic changes | Monitor ANC and organ-specific warning signs according to current prescribing information |
Clozapine still carries a risk of severe neutropenia, so ANC monitoring according to current prescribing information remains necessary. The FDA removed the Clozapine REMS participation and ANC reporting mandate in 2025, but that does not mean blood monitoring itself is no longer needed.
| Condition | Key clues | Priority action |
|---|---|---|
| Acute dystonia | Sudden spasms of the neck, jaw, or eyes; possible tongue or laryngeal involvement | Check the airway first, report immediately, and give the prescribed emergency medication while observing closely |
| Akathisia | Inner restlessness, constant movement, extreme distress | Assess suicide risk and medication timing, report to the prescriber; never interpret this as noncompliance |
| NMS | High fever, severe rigidity, altered consciousness, autonomic instability | Hold the suspected antipsychotic, call for emergency help, and monitor cooling, fluids, and organ function |
| Serotonin syndrome | Agitation, sweating, high fever, clonus, hyperreflexia, tremor, possible diarrhea | Hold serotonergic drugs, get an emergency evaluation, check for interactions, and provide supportive care |
| Lithium toxicity | Vomiting, diarrhea, coarse tremor, ataxia, slurred speech, confusion, seizures | Hold lithium, get an emergency evaluation, and check the level, kidney function, electrolytes, hydration status, and interactions |
| Drug class | Key characteristics | Nursing focus |
|---|---|---|
| Benzodiazepines | Rapid anxiety relief; possible sedation, memory effects, falls, respiratory depression, and dependence | Check for other depressants like opioids or alcohol, and prevent abrupt self-discontinuation |
| Buspirone | Not an immediate PRN effect — it works after regular dosing | Explain the onset of effect and check for dizziness and interactions |
| Non-benzodiazepine hypnotics | Sedation; possible complex sleep behaviors and falls | Ensure a safe sleep duration and environment after taking it, and check next-day functioning |
| Antihistamines and OTC products | Anticholinergic and sedative burden | Watch for confusion, urinary retention, constipation, and falls in older adults, and check for duplicate ingredients |
| Herbal products and supplements | Variability in ingredients and possible drug interactions | Don't assume "natural" means "safe" — share the complete list with the healthcare team |
ECT is one of the longest-used brain stimulation treatments for severe depressive episodes, and it may be considered in treatment-resistant depression or situations that need a rapid response, like catatonia, suicidality, or malnutrition. It is also used in specific circumstances for mania, schizoaffective disorder, and schizophrenia. A specialist team evaluates the individual risks, benefits, and alternatives for each client.
| Phase | What to check | Nursing focus |
|---|---|---|
| Before | Capacity to consent and legal procedures, history and anesthesia risks, medications, NPO status and prescribed tests | Provide understandable explanations, address questions and alternatives, and check teeth, prosthetics, and baseline cognition and memory |
| During | Brief general anesthesia and muscle relaxation; monitor oxygenation, blood pressure, and heart rate | A trained team monitors the airway, circulation, and seizure activity |
| Immediately after | Airway, breathing, vital signs, consciousness, orientation, pain, nausea, and fall risk | Don't let the client walk alone while confused; support them with repeated explanations and a safe recovery |
| Follow-up | Headache, muscle aches, nausea, temporary confusion and memory changes, and symptom response | Document findings compared to baseline, and report any severe or persistent changes immediately |
Check the indication, past response and allergies, pregnancy potential, kidney/liver/heart/metabolic status, seizure/fall history, and the complete medication list.
Track activation, suicidality, mania, sedation, orthostasis, rash, movement abnormalities, and the patient’s understanding of the medication early on.
Monitor effectiveness and functioning, along with weight, blood pressure, blood glucose, lipids, organ function, blood parameters, movement, and sexual function on a drug-specific basis.
Check for vomiting, diarrhea, fever, dietary changes, and the impact of new prescriptions or over-the-counter drugs on drug levels and toxicity.
Directly hand off the last dose given, the next dose due, lab schedules, prohibited combinations, warning signs, and contact pathways.
Confirm that target symptoms and functioning have improved and that harm is acceptable—not just that the patient “is taking it.”
Discuss efficacy goals, key side effects, alternatives, and the patient’s priorities together. Do not dismiss side effect complaints as “non-adherence.”
Identify cost, transportation, lab access, literacy, culture, stigma, daily routines, and side effects, then turn the plan into one that is actually feasible.
Drugs with withdrawal, relapse, or rebound risks require professional tapering. However, for life-threatening adverse reactions, holding the suspected drug and emergency evaluation come first.
Record symptom onset time, last dose, new medications and supplements, vital signs, labs, interventions, and responses in chronological order.
Do not assume it is dementia progression or psychosis. View it as acute delirium and assess oxygen, blood glucose, vital signs, infection, electrolytes, pain, medications, and voiding, while supporting orientation with glasses and hearing aids and ensuring fall safety.
Do not interpret this as the depression improving. Evaluate for manic or mixed features, suicide and impulsivity risk, bipolar history, and substance use, and report to the prescriber immediately.
Do not argue with the hallucination or predict violence based on the diagnosis alone. Specify the target, command, intent, means, access, past compliance, and control, along with substance use and delirium, and activate a safety pathway.
Do not view this as uncooperativeness. Stop the touch, briefly reorient them to the safe place and time here and now, assist with sensory grounding, and explain the next step to ask for permission and choice again.
Do not judge stability by appearance alone. Assess fall risk, vital signs, ECG, electrolytes, fluid status, compensatory behaviors, refeeding risk, and suicide safety together.
Before asking about withdrawal, the priorities are calling for emergency help, airway and ventilation support, naloxone, and respiratory monitoring. Even if they wake up, the effect may be temporary, so monitor for re-sedation and the need for repeat doses, and link to ongoing treatment.
Do not view this as simple anxiety or a common fine tremor. Hold the lithium, seek emergency evaluation, and check the blood level, kidney function, electrolytes, fluid status, and interactions.
Do not wait, attributing it only to common EPS or an infection. Consider neuroleptic malignant syndrome (NMS), hold the suspected drug, call for emergency help, and monitor ABCs, cooling, fluids, kidney function, muscle damage, and autonomic status.
This material is a study summary and is not a guideline for deciding an individual patient's diagnosis, risk level, drug choice, dosage, target blood level, admission, discharge, involuntary treatment, withdrawal protocol, ECT indication, consent, or emergency care. In actual practice, follow the latest prescribing information, current jurisdictional laws, institutional policies, prescriptions, and the judgment of pharmacists, poison control, mental health, emergency, and anesthesia specialist teams. The original sources were used only to confirm the existence of exam topics; questions, answers, choices, tables, and images have not been reproduced.
다음 이론을 계속 학습하려면 로그인하세요.
로그인하고 계속 학습필기노트, 하이라이터, 메모는 잘 쓰고 있어?
내보내줘운영진이 검토할게요!
마이페이지에서 차단한 회원을 관리할 수 있어요.